Novo's Suit Over Compounded Weight-Loss Drug Is Tossed
IP Law 360
NOVEMBER 9, 2023
A Florida federal judge has issued an order dismissing Novo Nordisk Inc.'s
companies novo-nordisk-a-s 
40 
IRA Drug Price Negotiation Program Litigation Updates – Denial of PI Motion and Motion to Dismiss in Chambers of Commerce Case and New Complaint Filed by Novo Nordisk
LexBlog IP
OCTOBER 2, 2023
Per the court’s order, the Plaintiffs have until October 13, 2023 to file an amended complaint. The government in turn filed a motion to dismiss the case for lack of subject matter jurisdiction. The court heard oral argument on the motions on September 15, and on September 29 issued an order denying both motions. ” (Order at 18).
Navigating the Waters of Intellectual Property: A Closer Look at the FTC’s Patent Listing Policy
LexBlog IP
SEPTEMBER 26, 2023
In this blog post, we will delve into the key aspects of the FTC’s Patent Listing Policy, exploring its significance and potential impact on the industry. That stay would prevent the generic drug company from introducing the generic drug for two and a half years. Novo Nordisk A/S. § 355(j)(5)(B)(iii).
Let's personalize your content